Christopher G. Kanakry

Aldehyde Dehydrogenase Expression Drives Human Regulatory T Cell Resistance to Posttransplantation Cyclophosphamide

Christopher G. Kanakry, Sudipto Ganguly, Marianna Zahurak et al. · Science Translational Medicine · 2013 · 358 citations

Life Sciences, Cell Biology, Immunology +12

Risk-stratified outcomes of nonmyeloablative HLA-haploidentical BMT with high-dose posttransplantation cyclophosphamide

Shannon R. McCurdy, Jennifer A. Kanakry, Margaret M. Showel et al. · Blood · 2015 · 300 citations · Full text

Medicine, Hematology, Immunology +14

Posttransplantation cyclophosphamide prevents graft-versus-host disease by inducing alloreactive T cell dysfunction and suppression

Lucas P. Wachsmuth, Michael T. Patterson, Michael Eckhaus et al. · Journal of Clinical Investigation · 2019 · 289 citations · Full text

Life Sciences, Hematology, Immunology +14

Multi-Institutional Study of Post-Transplantation Cyclophosphamide As Single-Agent Graft-Versus-Host Disease Prophylaxis After Allogeneic Bone Marrow Transplantation Using Myeloablative Busulfan and Fludarabine Conditioning

Christopher G. Kanakry, Paul V. O’Donnell, Terry Furlong et al. · Journal of Clinical Oncology · 2014 · 280 citations · Full text

Medicine, Hematology, Immunology +17

Donor CD4+ Foxp3+ regulatory T cells are necessary for posttransplantation cyclophosphamide-mediated protection against GVHD in mice

Sudipto Ganguly, Duncan B. Ross, Angela Panoskaltsis‐Mortari et al. · Blood · 2014 · 199 citations · Full text

Life Sciences, Immunology, Pathology +12